2021
DOI: 10.1089/jmf.2020.4866
|View full text |Cite
|
Sign up to set email alerts
|

Protective Role of Dietary Capsanthin in a Mouse Model of Nonalcoholic Fatty Liver Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 47 publications
0
3
0
Order By: Relevance
“…To examine the role of capsanthin, capsanthin (0.5 mg/kg of body weight/day) was orally administered to ApoE −/− mice daily. The capsanthin dose used corresponded to the dose that inhibits nonalcoholic fatty liver disease in mice [ 32 ]. The lipid-lowering agent, atorvastatin (20 mg/kg of body weight/day), was orally administered to ApoE −/− mice daily.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…To examine the role of capsanthin, capsanthin (0.5 mg/kg of body weight/day) was orally administered to ApoE −/− mice daily. The capsanthin dose used corresponded to the dose that inhibits nonalcoholic fatty liver disease in mice [ 32 ]. The lipid-lowering agent, atorvastatin (20 mg/kg of body weight/day), was orally administered to ApoE −/− mice daily.…”
Section: Resultsmentioning
confidence: 99%
“…Based on body surface area conversion, 0.5 mg/kg of capsanthin in mice equals 0.041 mg/kg of capsanthin in humans [ 48 ]. In a previous study, the capsanthin content in Raon red paprika was 34.33 mg/100 g dry weight [ 32 ]. For a similar anti-arteriosclerosis effect, capsanthin content was converted to 72 g of red paprika per day for a person weighing 60 kg.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation